NCT07413900

Biomarkers Study in Infants With Prior Neonatal Brain Injury

Recruiting now Last updated 17 February 2026

What this trial tests

trial in HIE - Hypoxic - Ischemic Encephalopathy in 100 participants. Currently enrolling.

Timeline

13 March 2023

Primary endpoint
15 March 2030

15 March 2030

Quick facts

Lead sponsor	University of Wisconsin, Madison
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	100
Start date	13 March 2023
Primary completion	15 March 2030
Estimated completion	15 March 2030
Sites	1 location across United States

Conditions studied

• HIE - Hypoxic - Ischemic Encephalopathy — all drugs for HIE - Hypoxic - Ischemic Encephalopathy →
• Perinatal Anoxic-ischemic Brain Injury — all drugs for Perinatal Anoxic-ischemic Brain Injury →
• Premature Birth — all drugs for Premature Birth →
• Healthy Participants — all drugs for Healthy Participants →

Sponsor

University of Wisconsin, Madison

Who can join

Adults 3 Months to 24 Months, any sex, with HIE - Hypoxic - Ischemic Encephalopathy or Perinatal Anoxic-ischemic Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research focuses on the long-term cognitive development of children, including healthy infants and those who had a perinatal brain injury. As part of this research study, children complete in-person games and assessments at UW-Madison University Hospital. Children will also take part in an EEG assessment. Parents will be asked to fill out questionnaires about their child's behavior and stress in the home.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.